Litcius/Paper detail

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

Luciano J. Costa, Benjamin A. Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C. Ye, Gordon Cook, Robert F. Cornell, Sarah A. Holstein, Qian Shi, James Omel, Natalie S. Callander, Wee Joo Chng, Vânia Hungria, Ângelo Maiolino, Edward A. Stadtmauer, Sergio Giralt, Marcelo C. Pasquini, Andrzej Jakubowiak, Gareth J. Morgan, Amrita Krishnan, Graham Jackson, Mohamad Mohty, María‐Victoria Mateos, Meletious A. Dimopoulos, Thierry Façon, Andrew Spencer, Jesús F. San Miguel, Parameswaran Hari, Saad Z. Usmani, Salomon Manier, Phillip McCarthy, Shaji Kumar, Francesca Gay, Bruno Paiva

2020Leukemia121 citationsDOIOpen Access PDF

Topics & Concepts

Clinical trialMedicineMinimal residual diseaseMultiple myelomaMedical physicsHarmonizationClinical endpointOncologyIntensive care medicineInternal medicineBone marrowPhysicsAcousticsMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer therapeutics and mechanisms
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials | Litcius